Inventor
Stephen Martin Courtney
Inventor
Abingdon, GB
Overview
Patents· 47 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds24%
A61KPreparations for medical, dental or toiletry purposes19%
C07CAcyclic or carbocyclic compounds17%
Y02ATechnologies for adaptation to climate change10%
C07HSugars3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C04D1%
PatentTitleYear
10,829,445N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors202010,792,273Nitroxyl donors with improved therapeutic index202010,730,828N-hydroxylsulfonamide derivatives as nitroxyl donors202010,723,704Pyrazolone derivatives as nitroxyl donors202010,548,872Pharmaceutical compositions comprising nitroxyl donors202010,517,847Nitroxyl donors with improved therapeutic index201910,487,049N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors201910,245,249Pharmaceutical compositions comprising nitroxyl donors201910,213,408Nitroxyl donors with improved therapeutic index201910,179,765N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors20199,981,918Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof20189,969,684N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors20189,968,584Nitroxyl donors with improved therapeutic index20189,932,303N-hydroxymethanesulfonamide nitroxyl donors20189,732,029'Nitroso compounds as nitroxyl donors and methods of use thereof'20179,725,402'Nitroso compounds as nitroxyl donors and methods of use thereof'20179,725,410'N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors'20179,682,938'Pyrazolone derivatives as nitroxyl donors'20179,649,310'Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20179,617,208'N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors'20179,586,896'Nitroxyl donors with improved therapeutic index'20179,487,498'N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors'20169,458,127'Bis-acylated hydroxylamine derivatives'20169,428,464'Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20169,260,422'Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20169,221,780'N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors'20159,156,804'Nitroxyl donors with improved therapeutic index'20159,145,373'Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20159,115,064'N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors'20159,102,688'Sulfonaminoquinoline hepcidin antagonists'20159,018,411'Bis-acylated hydroxylamine derivatives'20158,987,326'Nitroxyl donors with improved therapeutic index'20158,946,197'Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof'2015RE045314'N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors'20148,889,716'Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof'20148,791,134'Nitroso compounds as nitroxyl donors and methods of use thereof'20148,691,824'Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20148,674,132'N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors'20148,592,430'Quinazolin-oxime derivatives as Hsp90 inhibitors'20138,536,186'Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof'20138,318,705'Nitroso compounds as nitroxyl donors and methods of use thereof'20128,227,639'N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors'20128,030,356'N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors'20117,915,304'Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPT'20117,326,727'Furanthiazole derivatives as heparanase inhibitors'20087,138,425'Phthalimide carboxylic acid derivatives'20065,945,406'Therapeutic compounds with pyrimidine base'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999Based in Marcham, GB· patent location history
2006–2020Based in Oxfordshire, GB· patent location history
2008–2020Based in Abingdon, GB· patent location history
2011–2020Patents assigned to CARDIOXYL PHARMACEUTICALS INC (31)· patent assignee history
2011–2020Patents assigned to UNIV JOHNS HOPKINS (17)· patent assignee history
2012–2018Patents assigned to COURTNEY STEPHEN MARTIN (12)· patent assignee history
2013–2018Patents assigned to CHDI FOUNDATION INC (9)· patent assignee history
2013–2018Patents assigned to DOMINGUEZ CELIA (8)· patent assignee history
2014–2015Based in Stanford in the Vale, GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CARDIOXYL PHARMACEUTICALS INC | 31 | 2011–2020 |
| UNIV JOHNS HOPKINS | 17 | 2011–2020 |
| COURTNEY STEPHEN MARTINself | 12 | 2012–2018 |
| CHDI FOUNDATION INC | 9 | 2013–2018 |
| DOMINGUEZ CELIA | 8 | 2013–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Abingdon, GB | 32 | 2008–2020 |
| Oxfordshire, GB | 12 | 2006–2020 |
| Stanford in the Vale, GB | 2 | 2014–2015 |
| Marcham, GB | 1 | 1999 |